Screening for Hepatitis C in injecting drug users: a cost utility analysis (original) (raw)
The cost-effectiveness of testing for hepatitis C in former injecting drug users
Emanuela Castelnuovo
Health technology assessment (Winchester, England), 2006
View PDFchevron_right
The testing of people with any risk factor for hepatitis C in community pharmacies is cost‐effective
ryan buchanan
Journal of Viral Hepatitis, 2019
View PDFchevron_right
Eradicating hepatitis C: Are novel screening strategies for people who inject drugs cost-effective?
francesco manca
International Journal of Drug Policy, 2020
View PDFchevron_right
HCV Screening to Enable Early Treatment of Hepatitis C: A athematical Model to Analyse Costs and Outcomes in Two Populations
Andrea Tramarin
Current Pharmaceutical Design, 2008
View PDFchevron_right
Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysis
Kim Dalziel
Journal of Hepatology, 2003
View PDFchevron_right
Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults
mendel singer
The American Journal of Medicine, 2001
View PDFchevron_right
Cost-effectiveness of targeted screening for hepatitis C in The Netherlands
Andy Hoepelman
Epidemiology and Infection, 2011
View PDFchevron_right
Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature
Silvia Coretti
Risk Management and Healthcare Policy, 2015
View PDFchevron_right
Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States
Susana Williams Keeshin
JAMA Network Open, 2020
View PDFchevron_right
Uptake of Hepatitis C Screening, Characteristics of Patients Tested, and Intervention Costs in the BEST-C Study
Joseph Kannry
Hepatology, 2016
View PDFchevron_right
Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison
Noel Gill
BMC public health, 2006
View PDFchevron_right
Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens
Mark Eckman
Clinical Gastroenterology and Hepatology, 2019
View PDFchevron_right
Cost‐effectiveness of strategies for testing current hepatitis C virus infection
Chong Teo
Hepatology, 2015
View PDFchevron_right
Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison
Graham Betts-Symonds
International Journal of Drug Policy, 2021
View PDFchevron_right
In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered
Linda Henry
Liver International, 2017
View PDFchevron_right
Targets for Hepatitis C virus test uptake and case-finding among injecting drug users: In prisons and general practice
Roy Robertson
Addiction Research & Theory, 2010
View PDFchevron_right
Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era
Sergio Iannazzo
Alimentary Pharmacology & Therapeutics, 2019
View PDFchevron_right
Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost-effectiveness analysis
François Girardin
Journal of Viral Hepatitis, 2018
View PDFchevron_right
Economic consequences of the implementation of national screening program for chronic HCV infection
Guenka Petrova
Expert Review of Pharmacoeconomics & Outcomes Research, 2019
View PDFchevron_right
Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
Natasha Martin
View PDFchevron_right
Assessing the cost-effectiveness of hepatitis C screening strategies in France
Sylvie Deuffic-Burban
Journal of Hepatology, 2018
View PDFchevron_right
Screening for HCV
Michael Schwandt
Canadian Medical Association Journal, 2014
View PDFchevron_right
Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: an analysis of pooled data sets and economic modelling
Avril Taylor
Public Health Research
View PDFchevron_right
The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand
Terri Green
Drug and Alcohol Review, 2003
View PDFchevron_right
Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States
Mark Eckman
Clinical Infectious Diseases, 2013
View PDFchevron_right
Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?
David Prince
Canadian Journal of Gastroenterology and Hepatology
View PDFchevron_right
Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations
Mary Ramsay
Journal of Viral Hepatitis, 2008
View PDFchevron_right
Hepatitis C Infection Among Injecting Drug Users in England and Wales (1992-2006): There and Back Again?
Mary Ramsay
American Journal of Epidemiology, 2009
View PDFchevron_right
Case finding for hepatitis C in primary care: a cost utility analysis
Emanuela Castelnuovo
Family Practice, 2006
View PDFchevron_right
The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States
Jeffrey Townsend
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015
View PDFchevron_right
Economic evaluation of HCV testing approaches in low and middle income countries
Maria Servidone
BMC Infectious Diseases, 2017
View PDFchevron_right
Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland
Avril Taylor
Addiction (Abingdon, England), 2015
View PDFchevron_right
Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users
Nick Crofts
Australian and New Zealand Journal of Public Health, 1998
View PDFchevron_right
Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment
Eid Mansour
2021
View PDFchevron_right
Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection
W. Irving
Epidemiology and Infection, 2006
View PDFchevron_right